Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 03 Sept 2026 for Kiniksa Pharmaceuticals International, plc. Read the official filing
Filing timeline
BuySaleMark Ragosa
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Mark Ragosa: trading record in brief
Mark Ragosa, listed as finance chief, appears in our data through filings on Kiniksa Pharmaceuticals International, plc shares, published by SEC (Form 4). In total, 41 filings cover trades dated from 16 March 2022 to 1 September 2026.
Every open-market trade on record is a sale: 1 sale worth €430k. The rest of the record consists of 3 share grants and 37 option exercises. So far in 2026, the count stands at no purchases and 1 sale.
On 3 September 2026 came the latest disclosure, an option exercise in Kiniksa Pharmaceuticals International, plc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mark Ragosa
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations41 total
2,694 sharesClass A Ordinary ShareSEC:0001835458-26-000012:0
3,069 sharesClass A Ordinary ShareSEC:0001835458-26-000012:3
4,404 shares@ US$79.282.35% mcap8.4% of flowClass A Ordinary ShareSEC:0001835458-26-000012:4
1,750 sharesClass A Ordinary ShareSEC:0001835458-26-000012:1
1,591 sharesClass A Ordinary ShareSEC:0001835458-26-000012:2
1,303 shares@ US$48.944.3% of flowClass A Ordinary ShareSEC:0001835458-26-000010:1
2,694 sharesClass A Ordinary ShareSEC:0001835458-26-000010:0
2,510 shares@ US$48.137.5% of flowClass A Ordinary ShareSEC:0001835458-26-000008:1
5,187 sharesClass A Ordinary ShareSEC:0001835458-26-000008:0
2,036 shares@ US$22.891.2% of flowClass A Ordinary ShareSEC:0001835458-26-000006:0
8,374 shares@ US$12.972.8% of flowClass A Ordinary ShareSEC:0001835458-26-000004:0
12,000 shares@ US$41.8913.1% of flowClass A Ordinary ShareSEC:0001835458-26-000002:0
16,164 shares@ US$11.105.6% of flowClass A Ordinary ShareSEC:0001835458-25-000007:0
19,900 shares@ US$30.9320.6% of flowClass A Ordinary ShareSEC:0001835458-25-000005:0
100 shares@ US$30.930.1% of flowClass A Ordinary ShareSEC:0001835458-25-000003:0
1,592 sharesClass A Ordinary ShareSEC:0001415889-25-023553:0
18,889 shares@ US$22.8918.2% of flowClass A Ordinary ShareSEC:0001415889-25-021178:0
18,299 shares@ US$18.0017.3% of flowClass A Ordinary ShareSEC:0001415889-25-015778:0
20,000 shares@ US$15.5222.2% of flowClass A Ordinary ShareSEC:0001415889-25-011690:0
990 sharesClass A Ordinary ShareSEC:0001415889-25-011502:0
2,694 sharesClass A Ordinary ShareSEC:0001415889-25-010485:0
1,750 sharesClass A Ordinary ShareSEC:0001415889-25-010004:0
15,944 shares@ US$12.9715.5% of flowClass A Ordinary ShareSEC:0001415889-25-008846:0
872 sharesClass A Ordinary ShareSEC:0001415889-25-008622:0
36,372 shares@ US$11.9732.6% of flowClass A Ordinary ShareSEC:0001415889-25-008115:0
25 of 41 declarations
